Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522188 | SCV000619793 | uncertain significance | not provided | 2017-08-03 | criteria provided, single submitter | clinical testing | The c.1498+4A>G variant in the KIAA1109 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. Some in-silico splice prediction models predict that c.1498+4A>G may damage or destroy the splice donor site in intron 13, which is expected to cause abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of c.1498+4A>G in this individual is unknown. The c.1498+4A>G variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.1498+4A>G as a variant of uncertain significance. |
Ambry Genetics | RCV004023588 | SCV004913143 | uncertain significance | not specified | 2022-02-28 | criteria provided, single submitter | clinical testing | The c.1498+4A>G intronic alteration consists of a A to G substitution 4 nucleotides after exon 13 of the KIAA1109 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000522188 | SCV005190254 | uncertain significance | not provided | criteria provided, single submitter | not provided |